# INcrease Of VAgal TonE in CHF

Study · id `cardio:ct-nct01303718` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01303718](<https://clinicaltrials.gov/study/NCT01303718>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01303718

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 730 participants.

## Technical summary

Registry record NCT01303718. Randomized; no masking; primary purpose treatment. Start 2011-02 (registry gives no type); primary completion 2015-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 730 participants (enrolled count; ClinicalTrials.gov record NCT01303718, source copy `cardio:ctgov-nct01303718-2015-12-15`, retrieved 2026-10-26)
- Start date: 2011-02 (registry gives no type) (ClinicalTrials.gov record NCT01303718, source copy `cardio:ctgov-nct01303718-2015-12-15`, retrieved 2026-10-26)
- Primary completion: 2015-12 (actual) (ClinicalTrials.gov record NCT01303718, source copy `cardio:ctgov-nct01303718-2015-12-15`, retrieved 2026-10-26)
- Completion: 2015-12 (actual) (ClinicalTrials.gov record NCT01303718, source copy `cardio:ctgov-nct01303718-2015-12-15`, retrieved 2026-10-26)
- Countries: United States; Belgium; Germany; Israel; Netherlands; Poland; Serbia; United Kingdom (ClinicalTrials.gov record NCT01303718, source copy `cardio:ctgov-nct01303718-2015-12-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01303718-2015-12-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: INcrease Of VAgal TonE in CHF
- Acronym: INOVATE-HF
- Condition: Left Ventricular Dysfunction
- Condition: Heart Failure
- Intervention (Device): CardioFit® System
- Intervention (Other): Standard of Care
- Lead sponsor: BioControl Medical
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Vagus Nerve Stimulation for the Treatment of Heart Failure: The INOVATE-HF Trial (`cardio:pubmed-27058909`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 055b13ccc594645004f525b46dd2946075888be1d4ef2557661abfa3ca154798
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
